Get the Stockscreener App
73.00
3.27%
2.31
Pre-market:
73.94
0.94
+1.29%
Genedx Holdings Corp stock is traded at $73.00, with a volume of 874.86K.
It is up +3.27% in the last 24 hours and down -19.50% over the past month.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
See More
Previous Close:
$70.69
Open:
$70.14
24h Volume:
874.86K
Relative Volume:
1.25
Market Cap:
$2.14B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-23.47
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
-5.01%
1M Performance:
-19.50%
6M Performance:
-43.68%
1Y Performance:
-25.08%
1-Day Range:
$69.10
$73.53
1-Week Range:
$69.10
$80.00
52-Week Range:
$55.17
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
73.00 | 2.07B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
Jefferies reiterates GeneDx stock rating citing data advantage By Investing.com - Investing.com India
Jefferies reiterates GeneDx stock rating citing data advantage - Investing.com UK
GeneDx Holdings Corp. (WGS) Q4 earnings and revenues beat estimates - MSN
GeneDx Holdings Corp (WGS) Stock Price Down 4.09% on Mar 18 - GuruFocus
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL.com
GeneDx Holdings Corp. Q4 2025 earnings preview - MSN
Oracle Investment Management Inc. Sells 132,500 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Insider Selling: GeneDx (NASDAQ:WGS) CEO Sells 17,179 Shares of Stock - MarketBeat
Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells 5,706 Shares of Stock - MarketBeat
GeneDx CEO Stueland sells $1.32 million in WGS stock By Investing.com - Investing.com India
GeneDx CEO Stueland sells $1.32 million in WGS stock - Investing.com
GeneDx CFO Feeley sells $438k in shares after option exercise - Investing.com
GeneDx Holdings Corp. Experiences Revision in Stock Evaluation Amid Market Fluctuations - Markets Mojo
GeneDx (WGS) CEO exercises RSUs, sells 17,179 shares to cover taxes - Stock Titan
GeneDx (WGS) CFO sells shares to cover RSU tax obligations - Stock Titan
Aug Update: What are the risks of holding GeneDx Holdings CorpWeekly Profit Summary & Community Trade Idea Sharing Platform - baoquankhu1.vn
Aug Ideas: What are the risks of holding GeneDx Holdings CorpLong Setup & AI Forecasted Entry and Exit Points - baoquankhu1.vn
GeneDx Holdings Corp - Analytics Insight
GeneDx Holdings Corp. $WGS Stake Lessened by Fred Alger Management LLC - MarketBeat
Farallon Capital Management LLC Sells 321,677 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Casdin Capital LLC Has $323.99 Million Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Portolan Capital Management LLC Has $4.75 Million Stock Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
Genedx Earnings Call Signals Strong Genomics Growth - TipRanks
New Highs: What makes GeneDx Holdings Corp stock attractive today2026 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn
Quantitative Investment Management Buys Stake in GeneDx - National Today
Quantitative Investment Management LLC Buys New Position in GeneDx Holdings Corp. $WGS - MarketBeat
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat - MSN
100,284 Shares in GeneDx Holdings Corp. $WGS Bought by Capital International Investors - MarketBeat
Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? - NAI500
Aug Drivers: Does GeneDx Holdings Corp Equity Warrant stock benefit from AI growth2026 Setups & Technical Pattern Alert System - baoquankhu1.vn
GeneDx Holdings Corp. (WGS) latest stock news and headlines - Yahoo Finance Singapore
GeneDx stock falls as Natera launches competing rare disease test - Investing.com India
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com Australia
Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note? - Benzinga
Discipline and Rules-Based Execution in WGS Response - Stock Traders Daily
GeneDx at Barclays Conference: Expanding Genetic Testing Horizons - Investing.com South Africa
GeneDx at Barclays Conference: Expanding Genetic Testing Horizons By Investing.com - Investing.com India
AI Stocks: What is the Moat Score of GeneDx Holdings Corp2026 Rallies & Reliable Entry Point Trade Alerts - baoquankhu1.vn
$80,000 per child: gene tests shift kids from ER to planned care - Stock Titan
GeneDx Holdings (WGS) CFO exercises RSUs and sells shares to cover taxes - Stock Titan
WGSWW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
GeneDx (WGS) CEO exercises RSUs, sells shares only to cover taxes - Stock Titan
Why Is Zevra Therapeutics Stock Trading Higher Today? - Bitget
GeneDx outlines $540M–$555M 2026 revenue target as company accelerates market expansion with new sales force - MSN
GeneDx (NASDAQ:WGS) Trading Down 5.6%Time to Sell? - MarketBeat
Is GeneDx Holdings (WGS) Pricing In Its Sharp 27% Weekly Share Price Move? - Yahoo Finance
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
GeneDx Holdings Corp. to Launch Genetic Testing Program with Zevra Therapeutics, Inc. to Support Patients with Suspected Niemann-Pick Disease Type C - marketscreener.com
Eligible Niemann-Pick C patients get faster genetic tests at no charge - Stock Titan
A Look At GeneDx Holdings (WGS) Valuation After Strong Earnings And Genomics AI Developments - Yahoo Finance
Aug Drivers: What are the risks of holding GeneDx Holdings Corp2026 EndofYear Setup & Short-Term Trading Alerts - baoquankhu1.vn
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
2.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):